Compass Therapeutics CMPX
NASDAQ CMPX
$0.86 -0.04 (-4.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Non Operating Investment Income (2021 - 2022)

Updated

Compass Therapeutics (CMPX) recorded Non Operating Investment Income of $69,000 in Q2 2022.

Analysis

Compass Therapeutics (CMPX) Non Operating Investment Income (2021 - 2022) Analysis & Trends

For FY2020, Compass Therapeutics reported Non Operating Investment Income of -$281,000.

  • The Q2 2022 figure is the lowest quarterly Non Operating Investment Income since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Compass Therapeutics 154.88 Mn 154.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 69,000.00
Mar 31, 2021 44,000.00
API Access

Compass Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CMPX&period=max&api_key=YOUR_API_KEY